CLDN8 and colonic neoplasm: Wang, et al. [38] demonstrated that miR-223 acts as a pro-inflammatory factor in inflammatory bowel disease, a premalignant lesion that can lead to colon cancer, by targeting claudin 8 (CLDN8).